Report cover image

Global Oncology API Market Growth 2024-2030

Published Nov 19, 2024
Length 155 Pages
SKU # LPI19330542

Description

Global Oncology API Market Growth 2024-2030


Oncology API (Active Pharmaceutical Ingredient) refers to the active substances used in the formulation of drugs specifically for the treatment of cancer. These APIs are used to target and treat various types of cancer through different mechanisms of action. They include chemotherapy agents, targeted therapies, hormonal treatments, and immunotherapies, each with specific mechanisms of action. The development, manufacturing, and regulatory oversight of these APIs are critical to ensuring their safety, efficacy, and availability for cancer patients.

The global Oncology API market size is projected to grow from US$ 2093 million in 2024 to US$ 3188 million in 2030; it is expected to grow at a CAGR of 7.3% from 2024 to 2030.

LP Information, Inc. (LPI) ' newest research report, the “Oncology API Industry Forecast” looks at past sales and reviews total world Oncology API sales in 2023, providing a comprehensive analysis by region and market sector of projected Oncology API sales for 2024 through 2030. With Oncology API sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Oncology API industry.

This Insight Report provides a comprehensive analysis of the global Oncology API landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Oncology API portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Oncology API market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Oncology API and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Oncology API.

United States market for Oncology API is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.

China market for Oncology API is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.

Europe market for Oncology API is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.

Global key Oncology API players cover Olon Group, PolyPeptide, Glenmark Life Sciences, Sterling, Neopharma, etc. In terms of revenue, the global two largest companies occupied for a share nearly

% in 2023.

This report presents a comprehensive overview, market shares, and growth opportunities of Oncology API market by product type, application, key manufacturers and key regions and countries.

Segmentation by Type:
Alkylating Agents
Antimetabolites
Others

Segmentation by Application:
Chemotherapy
Targeted Therapy
Immunotherapy
Others

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
Olon Group
PolyPeptide
Glenmark Life Sciences
Sterling
Neopharma
Concord Biotech
Eisai Pharmaceuticals
Aspen API
Dr. Reddy's
CordenPharma
Natco
PROCOS SPA
Biocon
Shivalik Rasayan
Kekule Pharma
Aenova
GLS Pharma
Suanfarma
Fresenius Kabi Oncology
Hetero
Bachem

Key Questions Addressed in this Report

What is the 10-year outlook for the global Oncology API market?

What factors are driving Oncology API market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Oncology API market opportunities vary by end market size?

How does Oncology API break out by Type, by Application?



Please note: The report will take approximately 2 business days to prepare and deliver.

Table of Contents

155 Pages
*This is a tentative TOC and the final deliverable is subject to change.*
1 Scope of the Report
2 Executive Summary
3 Global by Company
4 World Historic Review for Oncology API by Geographic Region
5 Americas
6 APAC
7 Europe
8 Middle East & Africa
9 Market Drivers, Challenges and Trends
10 Manufacturing Cost Structure Analysis
11 Marketing, Distributors and Customer
12 World Forecast Review for Oncology API by Geographic Region
13 Key Players Analysis
14 Research Findings and Conclusion
How Do Licenses Work?
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.